Pfizer Independent Medical Education Grant Request for Proposals: Advancing Genomic Competence and Patient Centered Care in Metastatic Breast Cancer
Pfizer’s grant supports educational programs to boost healthcare professionals’ genomic knowledge and patient-centered communication in metastatic breast cancer care.
Funder: Pfizer Inc.
Due Dates: July 22, 2026 | July 20, 2026
Funding Amounts: Up to $100,000 per project (smaller requests encouraged); maximum project length 18 months
Summary: Supports integrated educational programs to improve healthcare professionals’ genomic knowledge and patient-centered communication in metastatic breast cancer care.
Description
This grant opportunity from Pfizer aims to fund the development of educational programs that advance the genomic competence of healthcare professionals and enhance patient-centered communication in the care of patients with metastatic breast cancer (mBC). The initiative addresses gaps in the selection, interpretation, and communication of genomic testing results, with a focus on supporting multidisciplinary teams in delivering consistent, evidence-based, and patient-focused genomic education. Funded projects should integrate curricula, case-based learning, and communication skills training to equip clinicians with the ability to interpret complex genomic data and engage patients in shared decision-making.
